Epigenetic regulation of BDNF expression according to antidepressant response

Molecular Psychiatry

Volumn 18, Issue 4, 2013, Pages 398-399

  Lopez, J P ^a   Mamdani, F ^a   Labonte, B ^a   Beaulieu, M M ^a   Yang, J P ^a   Berlim, M T ^a   Ernst, C ^a   Turecki, G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM;

DEPRESSION; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; EPIGENETICS; GENE EXPRESSION; HAMILTON SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HUMANS; MALE; PROMOTER REGIONS, GENETIC;

EID: 84884211454     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.38     Document Type: Letter

References (8)

1. Dwivedi Y. Neuropsychiatr Dis Treat 2009; 5: 433-449.
2. Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J et al. Mol Psychiatry 2011; 16: 1088-1095.
3. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. Genomics 2007; 90: 397-406.
4. Boulle F, van den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J et al. Mol Psychiatry advance online publication, 6 September 2011; doi:10.1038/mp.2011.107.
5. Tao X, West AE, Chen WG, Corfas G, Greenberg ME. Neuron 2002; 33: 383-395.
6. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y et al. Science 2003; 302: 890-893.
7. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Nat Neurosci 2006; 9: 519-525.
8. Chen ES, Ernst C, Turecki G. Int J Neuropsychopharmacol 2011; 14: 427-429.